Is lycopene an effective agent for preventing prostate cancer?

Cancer Prevention Research

Volumn 6, Issue 5, 2013, Pages 384-386

  Sporn, Michael B ^a   Liby, Karen T ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; LYCOPENE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B;

CELL PROTECTION; DOWN REGULATION; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; UPREGULATION;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CAROTENOIDS; HUMANS; MALE; PROSTATE; PROTEOME;

EID: 84877249822     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0026     Document Type: Review

References (20)

1. van Breemen RB, Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008; 269:339-51.
2. Haseen F, Cantwell MM, O'Sullivan JM, Murray LJ. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis 2009; 12:325-32.
3. Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: asystematic review. Maturitas 2012; 72:269-76.
4. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274:532-8. (Pubitemid 19261144)
5. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998; 56:35-51. (Pubitemid 28132684)
6. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999; 91:317-31. (Pubitemid 29102331)
7. Qui X, Yuan Y, Vaishnav A, Tessel MA, Nonn L, van Breemen RB. Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev Res 2013; 6:419-27.
8. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7:139-47. (Pubitemid 46160989)
9. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17:320-9.
10. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005; 4:177-86. (Pubitemid 40268075)
11. Mein JR, Lian F, Wang XD. Biological activity of lycopene metabolites: implications for cancer prevention. Nutr Rev 2008; 66:667-83.
12. Erdman JW Jr, Ford NA, Lindshield BL. Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys 2009; 483:229-35.
13. Konijeti R, Henning S, Moro A, Sheikh A, Elashoff D, Shapiro A, et al. Chemoprevention of prostate cancer with lycopene in the TRAMP model. Prostate 2010; 70:1547-54.
14. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testoster-one-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003; 95:1578-86. (Pubitemid 37455925)
15. van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, et al. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res 2011; 4:711-8.
16. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-5. (Pubitemid 26137973)
17. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 1996; 334:1189-90. (Pubitemid 26137981)
18. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35.
19. Sporn MB, Liby KT, Yore MM, Suh N, Albini A, Honda T, et al. Platforms and networks in triterpenoid pharmacology. Drug Dev Res 2007; 68:174-82. (Pubitemid 350085802)
20. Liby KT, Sporn MB. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 2012; 64:972-1003.